Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS England

This public procurement record has 1 release in its history.

Award

24 Jul 2025 at 10:01

Award Notice
Summary of the contracting process

NHS England has completed the procurement of its NHS Branded Medicines Tranche A. This framework agreement encompasses pharmaceutical products in London, South of England, and includes a national scope for adult influenza. The procurement process employed an open procedure above the threshold, with an award made on 25 June 2025. The contract period commences on 1 September 2025 and concludes on 31 August 2027. The value of the contract is approximately £261 million, covering a diverse delivery area including the British Overseas Territories, Channel Islands, Isle of Man, and Europe.

The awarded framework presents substantial business opportunities in the pharmaceutical industry, especially for suppliers of branded medicines. With the NHS England as the contracting authority, this agreement supports growth for companies that specialise in pharmaceutical goods and target SMEs as potential participants in this sector. The involvement of notable suppliers, such as Roche Products Ltd, Pfizer Ltd, and AstraZeneca, suggests a competitive environment encouraging innovation and expansion in branded medicinal formulations. Businesses concentrating on international and national distribution will particularly benefit from the diverse geographic coverage offered by this tender arrangement.

How relevant is this notice?

Notice Information

Notice Title

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

Notice Description

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-5ea01c9a-8442-488c-bb4a-cdfa18d54a6c
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/8a3e4a3c-0b35-41dd-a894-6b259747485a
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£261,895,933 £100M-£1B
Lots Value
Not specified
Awards Value
£261,895,933 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
24 Jul 20251 years ago
Submission Deadline
18 Mar 2025Expired
Future Notice Date
Not specified
Award Date
25 Jun 20251 years ago
Contract Period
1 Sep 2025 - 31 Aug 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
28
Supplier Names

Roche Products Ltd

Amgen Ltd

Seqirus UK Limited

Biogen Idec Limited

Teva UK Limited

Dr.Reddy's Laboratories (UK) Limited

Orifarm UK Ltd

Pfizer Ltd

Vifor Pharma UK Ltd

Accord-UK Ltd

Sandoz Ltd

Eli Lilly & Company Ltd

Chugai Pharma UK Ltd

Mylan

AVENTIS PHARMA LIMITED t-a Sanofi

Manx Healthcare Ltd

Janssen-Cilag Ltd

Novo Nordisk

Ranbaxy (UK) Ltd

Merck Serono Limited

Bayer Plc

Napp Pharmaceuticals Ltd

ASTRAZENECA UK LIMITED

CST Pharma Limited

Pharmacosmos UK Ltd

THORNTON & ROSS LIMITED

GlaxoSmithKline UK Limited

Gedeon Richter UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...